Clinical Trial Update: Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating prevention of atherosclerosis and heart disease in patients with systemic lupus erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Ischemic Heart Disease
• Systemic Lupus Erythematosus

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Systemic Lupus Erythematosus, Lupus | Phase 2 | Status: COMPLETED